Bank Of New York Mellon Corp Immunovant, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$15.27 - $19.72 $2.58 Million - $3.33 Million	169,074 New	169,074 $2.62 Billion
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $1.1 Million - $2.97 Million	167,510 New	167,510 $2.97 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $32,387 - $52,495	8,241 Added 5.83%	149,674 $835,000
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.65 $18,137 - $30,317	-5,366 Reduced 3.66%	141,433 $552,000
Q1 2022 May 11, 2022	BUY	$5.06 - $8.77 $4,720 - $8,182	933 Added 0.64%	146,799 $809,000
Q4 2021 Feb 11, 2022	BUY	$7.33 - $9.32 $39,530 - $50,262	5,393 Added 3.84%	145,866 $1.24 Million
Q3 2021 Nov 12, 2021	BUY	$7.01 - $11.37 $123,411 - $200,168	17,605 Added 14.33%	140,473 $1.22 Million
Q2 2021 Aug 11, 2021	SELL	$9.4 - $16.85 $245,170 - $439,481	-26,082 Reduced 17.51%	122,868 $1.3 Million
Q1 2021 May 13, 2021	SELL	$13.08 - $49.6 $237,545 - $900,785	-18,161 Reduced 10.87%	148,950 $2.39 Million
Q4 2020 Feb 09, 2021	BUY	$36.36 - $52.71 $460,499 - $667,572	12,665 Added 8.2%	167,111 $7.72 Million
Q3 2020 Nov 12, 2020	BUY	$22.61 - $38.9 $1.79 Million - $3.09 Million	79,342 Added 105.64%	154,446 $5.43 Million
Q2 2020 Aug 12, 2020	BUY	$13.87 - $28.44 $1.04 Million - $2.14 Million	75,104 New	75,104 $1.83 Million

212

66.9M

2.3M

631K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.